Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle

Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Pro...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Oncogenesis (New York, NY) Ročník 11; číslo 1; s. 54 - 12
Hlavní autori: Wang, Xia, Tian, Lu, Lu, Jingyi, Ng, Irene Oi-Lin
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London Nature Publishing Group UK 15.09.2022
Nature Publishing Group
Predmet:
ISSN:2157-9024, 2157-9024
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications.
AbstractList Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications.
Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications.Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications.
Abstract Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular cargoes, including proteins, lipids, nucleic acids (DNA, messenger and noncoding RNA), and metabolites to promote intercellular communication. Proteins and noncoding RNA are among the most abundant contents in exosomes; they have biological functions and are selectively packaged into exosomes. Exosomes derived from tumor, stromal and immune cells contribute to the multiple stages of cancer progression as well as resistance to therapy. In this review, we will discuss the biogenesis of exosomes and their roles in cancer development. Since specific contents within exosomes originate from their cells of origin, this property allows exosomes to function as valuable biomarkers. We will also discuss the potential use of exosomes as diagnostic and prognostic biomarkers or predictors for different therapeutic strategies for multiple cancers. Furthermore, the applications of exosomes as direct therapeutic targets or engineered vehicles for drugs are an important field of exosome study. Better understanding of exosome biology may pave the way to promising exosome-based clinical applications.
ArticleNumber 54
Author Wang, Xia
Lu, Jingyi
Ng, Irene Oi-Lin
Tian, Lu
Author_xml – sequence: 1
  givenname: Xia
  surname: Wang
  fullname: Wang, Xia
  organization: Department of Pathology, The University of Hong Kong, State Key Laboratory of Liver Research, The University of Hong Kong
– sequence: 2
  givenname: Lu
  surname: Tian
  fullname: Tian, Lu
  organization: Department of Pathology, The University of Hong Kong, State Key Laboratory of Liver Research, The University of Hong Kong
– sequence: 3
  givenname: Jingyi
  surname: Lu
  fullname: Lu, Jingyi
  organization: Department of Pathology, The University of Hong Kong, State Key Laboratory of Liver Research, The University of Hong Kong
– sequence: 4
  givenname: Irene Oi-Lin
  orcidid: 0000-0001-7532-2029
  surname: Ng
  fullname: Ng, Irene Oi-Lin
  email: iolng@hku.hk
  organization: Department of Pathology, The University of Hong Kong, State Key Laboratory of Liver Research, The University of Hong Kong
BookMark eNp9UstqHDEQFMEmdhz_QE4LueQyiZ4r6RIIfiQGgyHYZ6GRWrvazEobacYkf--ZHedhH6xLS91VpaKpN-gg5QQIvSP4I8FMfaqcMKUbTGmDMWekEa_QMSVCNhpTfvDf_Qid1rrB4xFLshTiNTpiS4K1wOQYfb_4lWveQl3Y5BfOJgdl0SzOo12lXPvo9v1dyX-ebcxbW35AmRn9GordwTCN7mEdXQdv0WGwXYXTx3qC7i4vbs--Ndc3X6_Ovlw3TijWN0ISp1oXJLE-WMwDaQPx2jsFBHTgWFFrqccYFFvKoB1rg5dYgcfOt4qyE3Q16_psN2ZX4ujrt8k2mn0jl5WxpZ8cGR-YJpgwIC3w4LymwkrLrOKceM_9qPV51toN7Ra8g9QX2z0RfTpJcW1W-d5oLqWiehT48ChQ8s8Bam-2sTroOpsgD9VQSQRnSmg8Qt8_g27yUNK4qgnFpVJaiBFFZ5QrudYC4a8Zgs2UADMnwIwJMPsEmImknpFc7G0f82Q6di9T2Uyt4z9pBeWfqxdYDxEvxy0
CitedBy_id crossref_primary_10_1038_s44328_025_00047_w
crossref_primary_10_3389_fimmu_2024_1368898
crossref_primary_10_3390_cells12030356
crossref_primary_10_1021_acsabm_4c01920
crossref_primary_10_3390_life14030408
crossref_primary_10_1016_j_prp_2025_155873
crossref_primary_10_1002_smtd_202400426
crossref_primary_10_3390_ncrna8060075
crossref_primary_10_3390_cancers15092479
crossref_primary_10_1016_j_abb_2024_110277
crossref_primary_10_1016_j_talanta_2025_128411
crossref_primary_10_1007_s11033_025_10535_x
crossref_primary_10_1016_j_bbcan_2025_189308
crossref_primary_10_1007_s00266_025_05073_7
crossref_primary_10_1016_j_ncrna_2024_11_005
crossref_primary_10_1007_s12031_025_02315_w
crossref_primary_10_1016_j_cca_2023_117705
crossref_primary_10_1016_j_omton_2024_200887
crossref_primary_10_1016_j_prp_2024_155766
crossref_primary_10_1080_10408347_2025_2530177
crossref_primary_10_1002_ctd2_208
crossref_primary_10_1016_j_ntm_2025_100096
crossref_primary_10_3390_pharmaceutics16050654
crossref_primary_10_34172_bi_31211
crossref_primary_10_1002_mabi_202300159
crossref_primary_10_1007_s12013_025_01730_5
crossref_primary_10_1016_j_talanta_2024_126619
crossref_primary_10_1093_bib_bbae075
crossref_primary_10_1097_TP_0000000000004693
crossref_primary_10_3389_fonc_2024_1459178
crossref_primary_10_1016_j_pbiomolbio_2024_08_002
crossref_primary_10_1128_msphere_00764_24
crossref_primary_10_1016_j_foodchem_2025_143425
crossref_primary_10_1007_s40291_024_00715_z
crossref_primary_10_1186_s12885_025_14375_7
crossref_primary_10_2147_IJN_S464249
crossref_primary_10_1016_j_lfs_2024_122985
crossref_primary_10_29333_ejgm_13456
crossref_primary_10_1016_j_prp_2024_155214
crossref_primary_10_1016_j_aca_2023_341910
crossref_primary_10_3390_ijms25063562
crossref_primary_10_1016_j_talanta_2025_128505
crossref_primary_10_3390_biology13090716
crossref_primary_10_1021_acsnano_5c06940
crossref_primary_10_1016_j_lfs_2024_122747
crossref_primary_10_3724_abbs_2025123
crossref_primary_10_1016_j_pscia_2025_100075
crossref_primary_10_1016_j_bcp_2025_117019
crossref_primary_10_1158_1940_6207_CAPR_22_0469
crossref_primary_10_1186_s40364_024_00685_8
crossref_primary_10_1016_j_bioorg_2024_107589
crossref_primary_10_1016_j_adcanc_2023_100103
crossref_primary_10_3390_molecules28104227
crossref_primary_10_1016_j_drup_2023_100937
crossref_primary_10_3390_membranes12121244
crossref_primary_10_1089_dcbr_2025_0019
crossref_primary_10_1016_j_lfs_2024_123280
crossref_primary_10_1016_j_tice_2025_102749
crossref_primary_10_33549_physiolres_935153
crossref_primary_10_1038_s41598_024_67934_6
crossref_primary_10_1186_s12014_024_09489_2
crossref_primary_10_1002_smll_202502763
crossref_primary_10_1063_5_0220840
crossref_primary_10_1002_ctd2_70063
crossref_primary_10_3390_biomedicines12081696
crossref_primary_10_1016_j_bbcan_2025_189315
crossref_primary_10_1186_s12935_024_03606_9
crossref_primary_10_3390_diseases12090221
crossref_primary_10_1016_j_vesic_2025_100089
crossref_primary_10_3390_pharmaceutics15082042
crossref_primary_10_1002_adfm_202418138
crossref_primary_10_3390_ijms241814356
crossref_primary_10_3389_fcell_2024_1372847
crossref_primary_10_3390_cancers15082256
crossref_primary_10_1021_acsabm_5c00318
crossref_primary_10_3389_fonc_2024_1437542
crossref_primary_10_1016_j_abb_2023_109718
crossref_primary_10_1021_acsabm_5c00955
crossref_primary_10_1515_biol_2022_0899
crossref_primary_10_7717_peerj_15798
crossref_primary_10_1021_acsabm_5c00288
crossref_primary_10_3389_fonc_2023_1131435
crossref_primary_10_3390_biomedicines12010123
crossref_primary_10_1136_jitc_2024_010928
crossref_primary_10_1016_j_biopha_2024_117735
crossref_primary_10_3390_ijms25010371
crossref_primary_10_1177_00368504251362350
crossref_primary_10_1016_j_prp_2025_155950
crossref_primary_10_1186_s12935_024_03522_y
crossref_primary_10_1039_D5NH00557D
crossref_primary_10_1016_j_nexres_2025_100434
crossref_primary_10_4252_wjsc_v17_i4_102917
crossref_primary_10_1038_s41390_025_03856_x
crossref_primary_10_1016_j_mtbio_2024_101433
crossref_primary_10_1021_jacs_5c11289
crossref_primary_10_23736_S1825_859X_23_00211_6
crossref_primary_10_1038_s41598_024_79425_9
crossref_primary_10_1016_j_gendis_2025_101682
crossref_primary_10_1016_j_bbcan_2023_188914
crossref_primary_10_3389_fphar_2025_1550208
crossref_primary_10_3390_cancers17121929
crossref_primary_10_1002_mco2_70388
crossref_primary_10_3390_cancers16152765
crossref_primary_10_1186_s12935_024_03379_1
crossref_primary_10_1039_D5TB00993F
crossref_primary_10_1165_rcmb_2022_0380ED
crossref_primary_10_3390_jpm14050482
crossref_primary_10_3390_diagnostics15050628
crossref_primary_10_1158_1541_7786_MCR_24_0052
crossref_primary_10_1007_s00216_023_04546_5
crossref_primary_10_3390_ijms26020526
crossref_primary_10_1016_j_jconrel_2023_11_005
crossref_primary_10_1016_j_talanta_2023_124548
crossref_primary_10_1002_adma_202303736
crossref_primary_10_1007_s10876_024_02676_z
crossref_primary_10_1016_j_bmi_2025_100007
crossref_primary_10_1080_14796694_2025_2539627
crossref_primary_10_1186_s12967_025_06883_8
crossref_primary_10_1016_j_heliyon_2024_e34460
crossref_primary_10_3390_ijms26073137
crossref_primary_10_1177_11795549231215966
crossref_primary_10_1186_s12943_024_01932_0
crossref_primary_10_3389_fimmu_2024_1473030
crossref_primary_10_3389_fonc_2023_1203359
crossref_primary_10_3390_ph18071005
crossref_primary_10_1002_jev2_70088
crossref_primary_10_1016_j_cca_2025_120532
crossref_primary_10_1016_j_canlet_2024_217084
crossref_primary_10_1016_j_ejpb_2024_114460
crossref_primary_10_1186_s12935_025_03806_x
crossref_primary_10_1186_s12935_024_03464_5
crossref_primary_10_3390_pharmaceutics15020663
crossref_primary_10_1371_journal_pone_0282814
crossref_primary_10_1016_j_drudis_2024_104061
crossref_primary_10_3389_fnins_2024_1426700
crossref_primary_10_1016_j_cej_2023_142842
crossref_primary_10_1186_s13054_025_05477_6
crossref_primary_10_1002_smtd_202500919
crossref_primary_10_1515_oncologie_2024_0571
crossref_primary_10_1016_j_critrevonc_2024_104341
crossref_primary_10_1016_j_cca_2024_120105
crossref_primary_10_1002_aidi_202500040
crossref_primary_10_3390_ijms252313045
crossref_primary_10_1002_cam4_70941
crossref_primary_10_1186_s43556_025_00280_9
crossref_primary_10_1002_iid3_1325
crossref_primary_10_3390_cancers16142552
crossref_primary_10_3390_ijms24020965
Cites_doi 10.7150/thno.46568
10.1016/j.canlet.2015.07.014
10.7150/jca.48531
10.1111/j.1365-2559.2007.02635.x
10.1186/1479-5876-3-9
10.1016/j.cell.2020.07.009
10.1016/j.cytogfr.2021.08.002
10.7150/thno.17092
10.1186/s12951-018-0437-z
10.1038/cr.2014.44
10.1074/jbc.C113.532267
10.1371/journal.pone.0004942
10.1038/ncb3169
10.1186/s12943-018-0897-7
10.1016/j.bcmd.2005.05.003
10.1056/NEJMoa1606774
10.1007/s10555-019-09783-8
10.3402/jev.v4.27031
10.1021/acsnano.5b07584
10.1186/s13046-019-1313-x
10.1016/S0092-8674(00)81688-8
10.1038/nature14581
10.1038/srep42339
10.1111/j.1600-0854.2009.00963.x
10.1016/j.canlet.2017.03.004
10.1080/20013078.2019.1697028
10.1007/s00383-016-3960-8
10.1200/JCO.2012.45.2011
10.1038/s41467-020-18311-0
10.1016/j.canlet.2020.08.030
10.1016/j.bbamem.2011.07.026
10.1056/NEJMra1704286
10.1186/s12951-022-01472-z
10.1016/j.jhep.2020.04.044
10.1038/nbt.2886
10.1038/s41467-017-01942-1
10.2147/OTT.S140062
10.1111/j.1582-4934.2005.tb00494.x
10.1158/0008-5472.CAN-16-2634
10.1002/advs.202002157
10.1016/S0959-8049(02)00166-1
10.1186/s12943-018-0831-z
10.1111/jcmm.13056
10.1007/s00018-017-2595-9
10.1080/10717544.2020.1748758
10.1186/s12964-021-00730-1
10.1016/j.ejps.2016.09.010
10.1038/s41598-019-41800-2
10.1186/s13046-019-1095-1
10.1016/j.canlet.2021.01.006
10.1016/j.bbrc.2013.07.044
10.3390/vaccines8040706
10.1038/s41388-020-01450-5
10.1172/JCI81137
10.1186/s12951-019-0563-2
10.1111/jcmm.12941
10.1016/j.tranon.2019.07.009
10.18632/aging.103366
10.1038/mt.2008.1
10.1002/stem.3113
10.4049/jimmunol.1400703
10.1165/rcmb.2017-0248OC
10.1016/j.celrep.2019.05.008
10.1186/s12951-021-00986-2
10.1016/j.tcb.2018.06.007
10.1080/20013078.2018.1435138
10.1158/1535-7163.MCT-14-0983
10.1038/nrm.2017.125
10.3892/ijo.2014.2256
10.1080/14756366.2020.1754814
10.7150/jca.31241
10.1038/emm.2014.114
10.2147/IJN.S218988
10.1038/s41417-020-00238-9
10.1158/1541-7786.MCR-19-0588
10.1007/s13277-015-3741-3
10.1007/s40291-017-0278-8
10.3402/jev.v5.31292
10.1186/s12916-018-1163-y
10.1038/bjc.2017.183
10.1038/ncomms3712
10.1021/acs.bioconjchem.8b00732
10.1038/nature15376
10.1016/j.cellimm.2020.104258
10.1182/blood-2008-04-153536
10.1038/s41586-018-0392-8
10.1016/j.actbio.2019.05.054
10.1016/j.biomaterials.2013.07.102
10.1002/ijc.31931
10.1158/1078-0432.CCR-05-0810
10.1186/s12943-017-0706-8
10.1002/mc.22935
10.1073/pnas.1017667108
10.1074/mcp.M112.021303
10.1371/journal.pone.0141448
10.18632/oncotarget.6045
10.1523/JNEUROSCI.2569-15.2016
10.1186/s12943-017-0714-8
10.1038/s41467-021-25990-w
10.1007/s00018-019-03052-1
10.1158/2159-8290.CD-15-1483
10.1002/jev2.12031
10.18632/oncotarget.14795
10.26508/lsa.201800093
10.1002/jev2.12134
10.4049/jimmunol.1901104
10.1038/ni854
10.1111/cas.14181
10.1186/1479-5876-10-134
10.1016/j.canlet.2021.05.017
10.1158/2159-8290.CD-20-1311
10.2147/IJN.S200036
10.1074/jbc.M115.671735
10.1002/eji.201343660
10.1080/20013078.2019.1703244
10.1016/j.bios.2020.112452
10.1096/fj.201601138RR
10.1038/emm.2015.68
10.1038/nature13954
10.1038/nm.2753
10.1080/20013078.2020.1809765
10.1016/j.talanta.2021.123089
10.1158/1055-9965.EPI-18-0569
10.1038/nature15756
10.15252/embj.201696003
10.3389/fcell.2022.728616
10.1038/sj.bjc.6605608
10.1038/ncb2502
10.1016/j.jhep.2011.04.026
10.18632/oncotarget.20881
10.1126/science.1153124
10.1093/annonc/mdx542
10.1038/bjc.2018.9
10.1309/AJCPAVFA8J3KHPRS
10.1371/journal.pone.0166027
10.1186/s12943-018-0817-x
10.1096/fj.202002730R
10.4161/onci.20897
10.1038/s41467-020-15569-2
10.1038/ncomms4591
10.3402/jev.v4.26659
10.1371/journal.pone.0215990
10.1038/bjc.2014.621
10.1038/cr.2015.82
10.1038/s41467-018-07947-8
10.1080/2162402X.2019.1593805
10.3390/cancers11030429
10.3402/jev.v2i0.20360
10.3390/cancers11101449
10.1038/s41388-019-0771-0
10.1002/jcb.27165
10.1186/s12943-019-1041-z
10.1186/s12943-022-01509-9
10.1002/jcb.26650
10.7150/thno.21945
10.3390/ijms23042180
10.1021/jacs.9b13960
10.1126/science.aau6977
10.1126/scitranslmed.aaz3426
10.1080/20013078.2020.1791450
10.3390/jcm5030030
10.1073/pnas.1618088114
10.1158/1078-0432.CCR-18-1941
ContentType Journal Article
Copyright The Author(s) 2022
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022. The Author(s).
Copyright_xml – notice: The Author(s) 2022
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022. The Author(s).
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1038/s41389-022-00431-5
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
ProQuest Health & Medical Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Science Database (ProQuest)
Biological Science Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic

CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2157-9024
EndPage 12
ExternalDocumentID oai_doaj_org_article_df391013e1be4fcd925a7a3a8441dd4d
PMC9477829
10_1038_s41389_022_00431_5
GrantInformation_xml – fundername: Innovation and Technology Commission (ITF)
  grantid: N/A
  funderid: https://doi.org/10.13039/501100003452
– fundername: Hong Kong Research Grants Council
– fundername: ;
– fundername: ;
  grantid: N/A
GroupedDBID 0R~
3V.
53G
5VS
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBLON
EBS
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
CITATION
7XB
8FK
K9.
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c583t-571c8bcf71adfa04f1bf1d9dc8e1e9f4082aa2d00e8367f9c3bfd708ed0cdb823
IEDL.DBID DOA
ISICitedReferencesCount 170
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000854766400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2157-9024
IngestDate Fri Oct 03 12:51:11 EDT 2025
Tue Nov 04 02:07:03 EST 2025
Thu Sep 04 15:51:22 EDT 2025
Sat Nov 29 14:29:38 EST 2025
Tue Nov 18 20:53:23 EST 2025
Sat Nov 29 02:53:39 EST 2025
Fri Feb 21 02:40:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c583t-571c8bcf71adfa04f1bf1d9dc8e1e9f4082aa2d00e8367f9c3bfd708ed0cdb823
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-7532-2029
OpenAccessLink https://doaj.org/article/df391013e1be4fcd925a7a3a8441dd4d
PMID 36109501
PQID 2714788955
PQPubID 2041913
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_df391013e1be4fcd925a7a3a8441dd4d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9477829
proquest_miscellaneous_2715438590
proquest_journals_2714788955
crossref_primary_10_1038_s41389_022_00431_5
crossref_citationtrail_10_1038_s41389_022_00431_5
springer_journals_10_1038_s41389_022_00431_5
PublicationCentury 2000
PublicationDate 2022-09-15
PublicationDateYYYYMMDD 2022-09-15
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-15
  day: 15
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: New York
PublicationTitle Oncogenesis (New York, NY)
PublicationTitleAbbrev Oncogenesis
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Dong, Holth, Kleinberg, Ruud, Elstrand, Tropé (CR147) 2009; 132
Yu, Gai, Li, Ding, Zheng, Zhang (CR166) 2019; 110
Vallabhaneni, Hassler, Abraham, Whitt, Mo, Atfi (CR6) 2016; 11
Yu, Zhang, Zhang, Han, Li, Mao (CR67) 2019; 10
CR39
Tian, Gong, Hu, Liu, Zhang, Zhang (CR45) 2020; 9
Li, Wu, Liu, Xu, Qiu, Huang (CR174) 2021; 19
CR36
Schierer, Ostalecki, Zinser, Lamprecht, Plosnita, Stich (CR63) 2018; 1
Li, Liu, Zang, Zhou, Zhang, Sun (CR51) 2020; 492
Segura, Amigorena, Thery (CR59) 2005; 35
Pitt, Charrier, Viaud, Andre, Besse, Chaput (CR158) 2014; 193
Smith, Selby, Johnston, Such (CR35) 2019; 30
Liu, Yuan, Pang, Xue, Yan (CR46) 2022; 239
Hoshino, Costa-Silva, Shen, Rodrigues, Hashimoto, Mark (CR33) 2015; 527
Viaud, Terme, Flament, Taieb, Andre, Novault (CR9) 2009; 4
Tang, Wong (CR87) 2015; 367
Zhang, Lu, Liu, Zhang, Lu (CR151) 2020; 35
Tauro, Greening, Mathias, Mathivanan, Ji, Simpson (CR107) 2013; 12
Reck, Rodriguez-Abreu, Robinson, Hui, Csoszi, Fulop (CR20) 2016; 375
Colombo, Moita, van Niel, Kowal, Vigneron, Benaroch (CR24) 2013; 126
Diaz, Bardelli (CR84) 2014; 32
Im, Shao, Park, Peterson, Castro, Weissleder (CR18) 2014; 32
Kajimoto, Okada, Miya, Zhang, Nakamura (CR26) 2013; 4
Quah, O’Neill (CR157) 2005; 9
Mikamori, Yamada, Eguchi, Hasegawa, Kishimoto, Tomimaru (CR133) 2017; 7
CR49
Li, Li, Zhou, Liu, Liu, Li (CR99) 2017; 16
van Niel, D’Angelo, Raposo (CR1) 2018; 19
CR48
Mao, Zhou, Tey, Ma, Yeung, Ng (CR83) 2020; 10
Buschow, Nolte-‘t Hoen, Niel, Pols, Broeke, Lauwen (CR27) 2009; 10
Stevic, Müller, Weber, Fasching, Karn, Marmé (CR132) 2018; 16
Sharma, Ludwig, Muller, Hong, Kirkwood, Ferrone (CR37) 2018; 7
Marleau, Chen, Joyce, Tullis (CR155) 2012; 10
Jakobsen, Paulsen, Bæk, Varming, Sorensen, Jørgensen (CR97) 2015; 4
Sharma, Huang, Brekken, Schroit (CR148) 2017; 117
Rubenich, Omizzollo, Szczepanski, Reichert, Whiteside, Ludwig (CR69) 2021; 61
Buscail, Chauvet, Quincy, Degrandi, Buscail, Lamrissi (CR102) 2019; 12
Zuo, Qi, Lu, Chen, Sun, Yang (CR7) 2020; 11
Thery, Duban, Segura, Veron, Lantz, Amigorena (CR60) 2002; 3
Zhu, Cao, Liang, Li, Hao, Meng (CR77) 2021; 506
Qazi, Gehrmann, Domange Jordo, Karlsson, Gabrielsson (CR62) 2009; 113
Mhawech-Fauceglia, Zhang, Terracciano, Sauter, Chadhuri, Herrmann (CR109) 2007; 50
Chen, Lin, Chiou, Harn (CR160) 2020; 32
Peng, Zhang, Yang, Zhang, Wei, Jiang (CR172) 2013; 34
CR141
Vallabhapurapu, Blanco, Sulaiman, Vallabhapurapu, Chu, Franco (CR146) 2015; 6
Overmiller, Pierluissi, Wermuth, Sauma, Martinez-Outschoorn, Tuluc (CR79) 2017; 31
Ito, Kudo, Higuchi, Otsuka, Tanaka, Fukunishi (CR76) 2021; 35
Liu, Chen, Liu (CR118) 2016; 32
Thakur, Zhang, Becker, Matei, Huang, Costa-Silva (CR143) 2014; 24
Trajkovic, Hsu, Chiantia, Rajendran, Wenzel, Wieland (CR25) 2008; 319
Chen, Liang, Zeng, Zhao, Guo, Zhong (CR16) 2020; 11
CR50
CR134
Liang, Zhu, Ali, Tian, Xu, Si (CR170) 2020; 18
Langemeyer, Fröhlich, Ungermann (CR31) 2018; 28
Costa-Silva, Aiello, Ocean, Singh, Zhang, Thakur (CR4) 2015; 17
Song, Trajkovic, Tsunemi, Krainc (CR29) 2016; 36
Alix-Panabières, Pantel (CR85) 2016; 6
Zhu, Shen, Yin, Yang, Wei, Chen (CR65) 2019; 38
Hessvik, Llorente (CR30) 2017; 75
Thind, Wilson (CR119) 2016; 5
Zhang, Wang, Wang, Zou, Mei, Peng (CR52) 2021; 28
Meng, He, Hao, Wang, Li, Zhu (CR165) 2020; 27
Bellavia, Raimondo, Calabrese, Forte, Cristaldi, Patinella (CR23) 2017; 7
Cappello, Logozzi, Campanella, Bavisotto, Marcilla, Properzi (CR90) 2017; 96
Oszvald, Szvicsek, Sandor, Kelemen, Soos, Paloczi (CR3) 2020; 38
Riedl, Rinner, Asslaber, Schaider, Walzer, Novak (CR145) 2011; 1808
CR150
Wu, Zhou, Mei, Wu, Mu, Chen (CR129) 2017; 21
Sun, Lee, Zhang, Kao, Teng, Yang (CR17) 2020; 11
Baietti, Zhang, Mortier, Melchior, Degeest, Geeraerts (CR28) 2012; 14
Yang, Feng, Liu, Tong, Wu, Li (CR75) 2020; 39
Antonyak, Li, Boroughs, Johnson, Druso, Bryant (CR74) 2011; 108
Wei, Wang, Wang, Han, Rong, Wang (CR57) 2020; 12
Fu, Zhou, Mi, Jiang (CR156) 2020; 8
Wei, Chen, Wang, Fu, Zhu, Wu (CR167) 2019; 14
Cao, Wang, Yu, Jiang, Li, Zhao (CR43) 2020; 166
Yuwen, Ma, Wang, Gao, Li, Xue (CR131) 2019; 28
Bellavia, Raimondo, Calabrese, Forte, Cristaldi, Patinella (CR169) 2017; 7
Cianciaruso, Beltraminelli, Duval, Nassiri, Hamelin, Mozes (CR164) 2019; 27
Im, Shao, Park, Peterson, Castro, Weissleder (CR108) 2014; 32
Catalano, O’Driscoll (CR152) 2020; 9
Shah, Patel, Freedman (CR88) 2018; 379
Bhan, Soleimani, Mandal (CR137) 2017; 77
Castillo, Bernard, San Lucas, Allenson, Capello, Kim (CR100) 2018; 29
Lea, Sharma, Yang, Zhu, Ward, Schroit (CR149) 2017; 8
Peinado, Aleckovic, Lavotshkin, Matei, Costa-Silva, Moreno-Bueno (CR98) 2012; 18
Tkach, Kowal, Zucchetti, Enserink, Jouve, Lankar (CR61) 2017; 36
Xiao, Dong, Zhen, Xia, Huang, Wang (CR103) 2020; 18
Alix-Panabières, Pantel (CR86) 2021; 11
Tsujiura, Ichikawa, Komatsu, Shiozaki, Takeshita, Kosuga (CR116) 2010; 102
CR71
Zhang, Li, Sun, Yue, Yang, Li (CR2) 2017; 397
Wang, Ding, Yaqoob, de Assuncao, Verma, Hirsova (CR58) 2015; 290
Fenselau, Ostrand-Rosenberg (CR72) 2021; 359
Sancho-Albero, Navascués, Mendoza, Sebastián, Arruebo, Martín-Duque (CR32) 2019; 17
Fornari, Ferracin, Trerè, Milazzo, Marinelli, Galassi (CR123) 2015; 10
Lobb, Becker, Wen, Wong, Wiegmans, Leimgruber (CR38) 2015; 4
CR117
Patel, Khan, Zubair, Srivastava, Khushman, Singh (CR173) 2019; 9
Di, Mi, Sun, Liu, Liu, Li (CR40) 2020; 10
Logozzi, Spugnini, Mizzoni, Di Raimo, Fais (CR93) 2019; 38
Chen, Huang, Zhang, Zhang, Wu, Xu (CR112) 2018; 560
Zhao, Zhang, Zhang, Yang, Zheng, Li (CR140) 2018; 17
Lee, Kim, Tak, Jang, Kweon, Park (CR138) 2019; 144
Tomimaru, Eguchi, Nagano, Wada, Kobayashi, Marubashi (CR115) 2012; 56
Hunter (CR104) 2000; 100
Huang, Hsueh, Shen, Guo, Huang, Zhang (CR78) 2021; 517
Gurung, Perocheau, Touramanidou, Baruteau (CR34) 2021; 19
CR124
CR125
Liu, Hu, Zhou, Chen, Wang, Liao (CR126) 2017; 10
Xie, Zhang, Zhao, Li, Xiang (CR73) 2013; 438
CR120
Sohn, Kim, Kang, Yang, Cho, Cho (CR122) 2015; 47
Lacy, Woeller, Thatcher, Pollock, Small, Sime (CR53) 2019; 60
CR80
Zhang, Zhan, Yao, Lowery, Zhang, Huang (CR56) 2015; 527
Giampieri, Piva, Occhipinti, Bittoni, Righetti, Pagliaretta (CR94) 2019; 14
Olmedillas-López, García-Arranz, García-Olmo (CR47) 2017; 21
Sun, Shi, Yang, Liu, Zhou, Wang (CR12) 2018; 17
Melo, Luecke, Kahlert, Fernandez, Gammon, Kaye (CR11) 2015; 523
Del, Marconcini, Pasquini, Rofi, Vivaldi, Bloise (CR113) 2018; 118
Vakhshiteh, Atyabi, Ostad (CR161) 2019; 14
Haluska, Dy, Adjei (CR154) 2002; 38
Morse, Garst, Osada, Khan, Hobeika, Clay (CR64) 2005; 3
Wang, Xie, Li, Sang, Yan, Li (CR153) 2021; 12
CR14
Yoshioka, Kosaka, Konishi, Ohta, Okamoto, Sonoda (CR44) 2014; 5
Yin, Ma, Huang, Lin, Zhou, Yan (CR66) 2019; 38
CR13
Lawson, Dickman, Towle, Jabalee, Javer, Garnis (CR81) 2019; 58
Jeong, Park, Pathania, Castro, Weissleder, Lee (CR42) 2016; 10
CR96
CR95
Liu, Mendes, Berkman (CR110) 2014; 44
Dai, Wan, Wang, Zhou, Xiu, Chen (CR15) 2005; 11
CR92
CR91
Wei, Wu, Kang, Sun, Heskia, Pachot (CR41) 2020; 9
Li, Chen, Guo, Zhou, Jia, Peng (CR101) 2017; 21
Wang, Hou, Li, Duan, Gao, Song (CR121) 2014; 2014
Hoshino, Kim, Bojmar, Gyan, Cioffi, Hernandez (CR111) 2020; 182
Qu, Wu, Wu, Ji, Qiang, Jiang (CR128) 2017; 8
Caivano, Laurenzana, De Luca, La Rocca, Simeon, Trino (CR89) 2015; 36
Patel, Kurzrock (CR114) 2015; 14
Zhang, Liu, Zhang, Huang, Tang, Chai (CR168) 2022; 20
Yoon, Kim, Choi (CR70) 2015; 47
Guo, Duan, Zhang, Wang, He, Liu (CR8) 2020; 205
Tumeh, Harview, Yearley, Shintaku, Taylor, Robert (CR19) 2014; 515
Gao, Wei, de Assuncao, Liu, Hu, Ibrahim (CR54) 2020; 73
Sun, Yang, Zhou, Wang, Song, Li (CR136) 2018; 17
Yuwen, Sheng, Liu, Wenyu, Shu (CR130) 2017; 21
Hu, Sheng, Kwak, Shi, Yu, Lee (CR135) 2017; 8
Chen, Wang, Zhu, Xu, Liu, Li (CR171) 2022; 10
CR21
Rayamajhi, Nguyen, Marasini, Aryal (CR22) 2019; 94
CR105
Sugimachi, Matsumura, Hirata, Uchi, Ueda, Ueo (CR127) 2015; 112
Xue, Chen, Xiang, Wang, Chen, Pan (CR139) 2017; 16
Dai, Wei, Wu, Zhou, Wei, Huang (CR163) 2008; 16
Mao, Tey, Yeung, Kwong, Fung, Chung (CR82) 2020; 7
Kahlert, Melo, Protopopov, Tang, Seth, Koch (CR144) 2014; 289
Munich, Sobo-Vujanovic, Buchser, Beer-Stolz, Vujanovic (CR10) 2012; 1
Pitt, Andre, Amigorena, Soria, Eggermont, Kroemer (CR159) 2016; 126
Szvicsek, Oszvald, Szabo, Sandor, Kelemen, Soos (CR55) 2019; 76
Lee, Kim, Kim (CR68) 2014; 44
Li, Zheng, Bao, Li, Guo, Zhao (CR142) 2015; 25
Shi, Yang, Monsel, Yan, Dai, Zhao (CR162) 2021; 10
Miyazoe, Miuma, Miyaaki, Kanda, Nakashiki, Sasaki (CR5) 2020; 12
CR106
X Zhu (431_CR65) 2019; 38
F Fornari (431_CR123) 2015; 10
MA Morse (431_CR64) 2005; 3
S Olmedillas-López (431_CR47) 2017; 21
W Li (431_CR99) 2017; 16
J Lea (431_CR149) 2017; 8
H Im (431_CR18) 2014; 32
BK Thakur (431_CR143) 2014; 24
431_CR36
J Guo (431_CR8) 2020; 205
R Wang (431_CR58) 2015; 290
L Zhang (431_CR56) 2015; 527
MA Antonyak (431_CR74) 2011; 108
B Zuo (431_CR7) 2020; 11
431_CR150
H Wang (431_CR121) 2014; 2014
MK Tang (431_CR87) 2015; 367
C Cianciaruso (431_CR164) 2019; 27
YR Lee (431_CR138) 2019; 144
L Chen (431_CR171) 2022; 10
G Wang (431_CR153) 2021; 12
S Jeong (431_CR42) 2016; 10
Y Yoshioka (431_CR44) 2014; 5
X Mao (431_CR82) 2020; 7
F Vakhshiteh (431_CR161) 2019; 14
R Giampieri (431_CR94) 2019; 14
W Liu (431_CR118) 2016; 32
SI Buschow (431_CR27) 2009; 10
HP Dong (431_CR147) 2009; 132
C Kahlert (431_CR144) 2014; 289
J Gao (431_CR54) 2020; 73
A Thind (431_CR119) 2016; 5
431_CR39
K Sugimachi (431_CR127) 2015; 112
Y Xie (431_CR73) 2013; 438
Q Peng (431_CR172) 2013; 34
DL Yuwen (431_CR130) 2017; 21
SA Smith (431_CR35) 2019; 30
JM Pitt (431_CR158) 2014; 193
Y Cao (431_CR43) 2020; 166
KR Jakobsen (431_CR97) 2015; 4
J Castillo (431_CR100) 2018; 29
R Zhao (431_CR140) 2018; 17
H Liu (431_CR46) 2022; 239
431_CR50
DS Rubenich (431_CR69) 2021; 61
H Wu (431_CR129) 2017; 21
Y Li (431_CR142) 2015; 25
D Bellavia (431_CR169) 2017; 7
M Tkach (431_CR61) 2017; 36
N Sun (431_CR17) 2020; 11
ZX Chen (431_CR16) 2020; 11
Y Tian (431_CR45) 2020; 9
A Oszvald (431_CR3) 2020; 38
431_CR134
S Viaud (431_CR9) 2009; 4
431_CR48
S Riedl (431_CR145) 2011; 1808
MF Baietti (431_CR28) 2012; 14
431_CR49
Z Yin (431_CR66) 2019; 38
X Yu (431_CR67) 2019; 10
S Dai (431_CR15) 2005; 11
C Fenselau (431_CR72) 2021; 359
T Hunter (431_CR104) 2000; 100
JM Pitt (431_CR159) 2016; 126
H Wei (431_CR167) 2019; 14
P Song (431_CR29) 2016; 36
E Segura (431_CR59) 2005; 35
F Wei (431_CR57) 2020; 12
M Mikamori (431_CR133) 2017; 7
T Liu (431_CR110) 2014; 44
M Catalano (431_CR152) 2020; 9
NP Hessvik (431_CR30) 2017; 75
SA Melo (431_CR11) 2015; 523
H Peinado (431_CR98) 2012; 18
T Kajimoto (431_CR26) 2013; 4
AM Overmiller (431_CR79) 2017; 31
P Wei (431_CR41) 2020; 9
AM Marleau (431_CR155) 2012; 10
C Alix-Panabières (431_CR86) 2021; 11
LA Diaz Jr (431_CR84) 2014; 32
M Reck (431_CR20) 2016; 375
431_CR141
Y Tomimaru (431_CR115) 2012; 56
W Meng (431_CR165) 2020; 27
D Bellavia (431_CR23) 2017; 7
M Ito (431_CR76) 2021; 35
KC Vallabhaneni (431_CR6) 2016; 11
R Sharma (431_CR148) 2017; 117
E Buscail (431_CR102) 2019; 12
YJ Li (431_CR174) 2021; 19
PC Tumeh (431_CR19) 2014; 515
HD Lee (431_CR68) 2014; 44
ReM Del (431_CR113) 2018; 118
YS Chen (431_CR160) 2020; 32
D Yuwen (431_CR131) 2019; 28
S Schierer (431_CR63) 2018; 1
431_CR71
A Hoshino (431_CR111) 2020; 182
W Sohn (431_CR122) 2015; 47
MM Shi (431_CR162) 2021; 10
M Colombo (431_CR24) 2013; 126
RJ Lobb (431_CR38) 2015; 4
Z Sun (431_CR12) 2018; 17
H Zhang (431_CR151) 2020; 35
C Fu (431_CR156) 2020; 8
Y Zhang (431_CR168) 2022; 20
SR Yoon (431_CR70) 2015; 47
Z Szvicsek (431_CR55) 2019; 76
R Shah (431_CR88) 2018; 379
S Rayamajhi (431_CR22) 2019; 94
D Xiao (431_CR103) 2020; 18
SD Vallabhapurapu (431_CR146) 2015; 6
431_CR117
J Li (431_CR51) 2020; 492
K Trajkovic (431_CR25) 2008; 319
431_CR80
S Munich (431_CR10) 2012; 1
J Hu (431_CR135) 2017; 8
M Xue (431_CR139) 2017; 16
C Thery (431_CR60) 2002; 3
X Zhang (431_CR52) 2021; 28
GK Patel (431_CR173) 2019; 9
Z Sun (431_CR136) 2018; 17
431_CR124
J Lawson (431_CR81) 2019; 58
431_CR120
H Im (431_CR108) 2014; 32
M Tsujiura (431_CR116) 2010; 102
Q Huang (431_CR78) 2021; 517
M Logozzi (431_CR93) 2019; 38
B Yang (431_CR75) 2020; 39
G Liang (431_CR170) 2020; 18
W Liu (431_CR126) 2017; 10
A Hoshino (431_CR33) 2015; 527
431_CR125
P Sharma (431_CR37) 2018; 7
BJ Tauro (431_CR107) 2013; 12
Z Qu (431_CR128) 2017; 8
BJC Quah (431_CR157) 2005; 9
431_CR91
G van Niel (431_CR1) 2018; 19
431_CR92
A Bhan (431_CR137) 2017; 77
F Cappello (431_CR90) 2017; 96
431_CR95
431_CR96
431_CR13
431_CR14
J Li (431_CR101) 2017; 21
C Alix-Panabières (431_CR85) 2016; 6
G Chen (431_CR112) 2018; 560
I Stevic (431_CR132) 2018; 16
S Dai (431_CR163) 2008; 16
SH Lacy (431_CR53) 2019; 60
P Haluska (431_CR154) 2002; 38
H Di (431_CR40) 2020; 10
S Gurung (431_CR34) 2021; 19
B Costa-Silva (431_CR4) 2015; 17
431_CR21
L Langemeyer (431_CR31) 2018; 28
X Mao (431_CR83) 2020; 10
M Sancho-Albero (431_CR32) 2019; 17
Y Miyazoe (431_CR5) 2020; 12
P Mhawech-Fauceglia (431_CR109) 2007; 50
A Caivano (431_CR89) 2015; 36
G Zhu (431_CR77) 2021; 506
KR Qazi (431_CR62) 2009; 113
431_CR105
Z Zhang (431_CR2) 2017; 397
431_CR106
SP Patel (431_CR114) 2015; 14
M Yu (431_CR166) 2019; 110
References_xml – ident: CR150
– volume: 10
  start-page: 9303
  year: 2020
  end-page: 14
  ident: CR40
  article-title: Nanozyme-assisted sensitive profiling of exosomal proteins for rapid cancer diagnosis
  publication-title: Theranostics
  doi: 10.7150/thno.46568
– volume: 367
  start-page: 26
  year: 2015
  end-page: 33
  ident: CR87
  article-title: Exosomes: Emerging biomarkers and targets for ovarian cancer
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.07.014
– volume: 11
  start-page: 6445
  year: 2020
  end-page: 53
  ident: CR16
  article-title: Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis
  publication-title: J Cancer
  doi: 10.7150/jca.48531
– volume: 50
  start-page: 472
  year: 2007
  end-page: 83
  ident: CR109
  article-title: Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2007.02635.x
– volume: 3
  year: 2005
  ident: CR64
  article-title: A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-3-9
– ident: CR39
– volume: 182
  start-page: 1044
  year: 2020
  end-page: 61.e1018
  ident: CR111
  article-title: Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
  publication-title: Cell
  doi: 10.1016/j.cell.2020.07.009
– volume: 61
  start-page: 16
  year: 2021
  end-page: 26
  ident: CR69
  article-title: Small extracellular vesicle-mediated bidirectional crosstalk between neutrophils and tumor cells
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2021.08.002
– volume: 7
  start-page: 1333
  year: 2017
  end-page: 45
  ident: CR23
  article-title: Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth
  publication-title: Theranostics
  doi: 10.7150/thno.17092
– volume: 17
  start-page: 16
  year: 2019
  ident: CR32
  article-title: Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells
  publication-title: J Nanobiotechnology
  doi: 10.1186/s12951-018-0437-z
– volume: 24
  start-page: 766
  year: 2014
  end-page: 9
  ident: CR143
  article-title: Double-stranded DNA in exosomes: a novel biomarker in cancer detection
  publication-title: Cell Res
  doi: 10.1038/cr.2014.44
– ident: CR80
– volume: 289
  start-page: 3869
  year: 2014
  end-page: 75
  ident: CR144
  article-title: Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer
  publication-title: J Biol Chem
  doi: 10.1074/jbc.C113.532267
– volume: 4
  start-page: e4942
  year: 2009
  ident: CR9
  article-title: Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0004942
– volume: 17
  start-page: 816
  year: 2015
  end-page: 26
  ident: CR4
  article-title: Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb3169
– ident: CR106
– volume: 17
  year: 2018
  ident: CR12
  article-title: Effect of exosomal miRNA on cancer biology and clinical applications
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0897-7
– volume: 35
  start-page: 89
  year: 2005
  end-page: 93
  ident: CR59
  article-title: Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses
  publication-title: Blood Cells Mol Dis
  doi: 10.1016/j.bcmd.2005.05.003
– volume: 375
  start-page: 1823
  year: 2016
  end-page: 33
  ident: CR20
  article-title: Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
  publication-title: N. Engl J Med
  doi: 10.1056/NEJMoa1606774
– volume: 38
  start-page: 93
  year: 2019
  end-page: 101
  ident: CR93
  article-title: Extracellular acidity and increased exosome release as key phenotypes of malignant tumors
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-019-09783-8
– volume: 4
  start-page: 27031
  year: 2015
  ident: CR38
  article-title: Optimized exosome isolation protocol for cell culture supernatant and human plasma
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v4.27031
– volume: 10
  start-page: 1802
  year: 2016
  end-page: 9
  ident: CR42
  article-title: Integrated Magneto-Electrochemical Sensor for Exosome Analysis
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b07584
– volume: 38
  start-page: 310
  year: 2019
  ident: CR66
  article-title: Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-beta signaling pathway
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1313-x
– ident: CR71
– volume: 100
  start-page: 113
  year: 2000
  end-page: 27
  ident: CR104
  article-title: Signaling-2000 and beyond
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81688-8
– volume: 523
  start-page: 177
  year: 2015
  end-page: 82
  ident: CR11
  article-title: Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
  publication-title: Nature
  doi: 10.1038/nature14581
– volume: 7
  year: 2017
  ident: CR133
  article-title: MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
  publication-title: Sci Rep
  doi: 10.1038/srep42339
– volume: 10
  start-page: 1528
  year: 2009
  end-page: 42
  ident: CR27
  article-title: MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2009.00963.x
– volume: 397
  start-page: 33
  year: 2017
  end-page: 42
  ident: CR2
  article-title: Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2017.03.004
– ident: CR92
– volume: 9
  start-page: 1697028
  year: 2020
  ident: CR45
  article-title: Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2019.1697028
– volume: 32
  start-page: 1059
  year: 2016
  end-page: 65
  ident: CR118
  article-title: Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study
  publication-title: Pediatr Surg Int
  doi: 10.1007/s00383-016-3960-8
– volume: 32
  start-page: 579
  year: 2014
  end-page: 86
  ident: CR84
  article-title: Liquid biopsies: genotyping circulating tumor DNA
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.45.2011
– volume: 11
  year: 2020
  ident: CR17
  article-title: Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-18311-0
– volume: 492
  start-page: 71
  year: 2020
  end-page: 83
  ident: CR51
  article-title: Small extracellular vesicle-bound vascular endothelial growth factor secreted by carcinoma-associated fibroblasts promotes angiogenesis in a bevacizumab-resistant manner
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2020.08.030
– volume: 1808
  start-page: 2638
  year: 2011
  end-page: 45
  ident: CR145
  article-title: In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamem.2011.07.026
– volume: 379
  start-page: 958
  year: 2018
  end-page: 66
  ident: CR88
  article-title: Circulating Extracellular Vesicles in Human Disease
  publication-title: N. Engl J Med
  doi: 10.1056/NEJMra1704286
– volume: 20
  year: 2022
  ident: CR168
  article-title: Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
  publication-title: J Nanobiotechnology
  doi: 10.1186/s12951-022-01472-z
– volume: 73
  start-page: 1144
  year: 2020
  end-page: 54
  ident: CR54
  article-title: Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2020.04.044
– volume: 32
  start-page: 490
  year: 2014
  end-page: U219.
  ident: CR18
  article-title: Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2886
– ident: CR36
– volume: 8
  year: 2017
  ident: CR135
  article-title: A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01942-1
– volume: 32
  start-page: 490
  year: 2014
  end-page: 5
  ident: CR108
  article-title: Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2886
– volume: 10
  start-page: 3843
  year: 2017
  end-page: 51
  ident: CR126
  article-title: Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S140062
– volume: 9
  start-page: 643
  year: 2005
  end-page: 54
  ident: CR157
  article-title: Maturation of function in dendritic cells for tolerance and immunity
  publication-title: J CELL MOL MED
  doi: 10.1111/j.1582-4934.2005.tb00494.x
– volume: 77
  start-page: 3965
  year: 2017
  end-page: 81
  ident: CR137
  article-title: Long Noncoding RNA and Cancer: A New Paradigm
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-2634
– volume: 7
  start-page: 2002157
  year: 2020
  ident: CR82
  article-title: Nidogen 1-Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1
  publication-title: Adv Sci (Weinh)
  doi: 10.1002/advs.202002157
– volume: 38
  start-page: 1685
  year: 2002
  end-page: 1700
  ident: CR154
  article-title: Farnesyl transferase inhibitors as anticancer agents
  publication-title: EUR J CANCER
  doi: 10.1016/S0959-8049(02)00166-1
– ident: CR91
– volume: 17
  year: 2018
  ident: CR136
  article-title: Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0831-z
– volume: 21
  start-page: 1228
  year: 2017
  end-page: 36
  ident: CR129
  article-title: Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.13056
– volume: 75
  start-page: 193
  year: 2017
  end-page: 208
  ident: CR30
  article-title: Current knowledge on exosome biogenesis and release
  publication-title: Cell Mol life Sci: CMLS
  doi: 10.1007/s00018-017-2595-9
– volume: 27
  start-page: 585
  year: 2020
  end-page: 98
  ident: CR165
  article-title: Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source
  publication-title: Drug Deliv
  doi: 10.1080/10717544.2020.1748758
– volume: 19
  start-page: 47
  year: 2021
  ident: CR34
  article-title: The exosome journey: from biogenesis to uptake and intracellular signalling
  publication-title: Cell Commun Signal
  doi: 10.1186/s12964-021-00730-1
– ident: CR117
– volume: 96
  start-page: 93
  year: 2017
  end-page: 98
  ident: CR90
  article-title: Exosome levels in human body fluids: A tumor marker by themselves?
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2016.09.010
– volume: 9
  year: 2019
  ident: CR173
  article-title: Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-41800-2
– volume: 38
  start-page: 81
  year: 2019
  ident: CR65
  article-title: Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1095-1
– volume: 506
  start-page: 11
  year: 2021
  end-page: 22
  ident: CR77
  article-title: Small extracellular vesicles containing miR-192/215 mediate hypoxia-induced cancer-associated fibroblast development in head and neck squamous cell carcinoma
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2021.01.006
– volume: 438
  start-page: 152
  year: 2013
  end-page: 5
  ident: CR73
  article-title: Natural CD8(+)25(+) regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2013.07.044
– volume: 2014
  start-page: 864894
  year: 2014
  ident: CR121
  article-title: Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma
  publication-title: Biomed Res Int
– volume: 8
  start-page: 706
  year: 2020
  ident: CR156
  article-title: DC-Based Vaccines for Cancer Immunotherapy
  publication-title: Vaccines (Basel)
  doi: 10.3390/vaccines8040706
– volume: 39
  start-page: 6529
  year: 2020
  end-page: 43
  ident: CR75
  article-title: High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
  publication-title: Oncogene
  doi: 10.1038/s41388-020-01450-5
– ident: CR134
– ident: CR13
– volume: 126
  start-page: 1224
  year: 2016
  end-page: 32
  ident: CR159
  article-title: Dendritic cell-derived exosomes for cancer therapy
  publication-title: J CLIN INVEST
  doi: 10.1172/JCI81137
– volume: 18
  start-page: 10
  year: 2020
  ident: CR170
  article-title: Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
  publication-title: J Nanobiotechnology
  doi: 10.1186/s12951-019-0563-2
– volume: 21
  start-page: 838
  year: 2017
  end-page: 47
  ident: CR101
  article-title: GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.12941
– volume: 12
  start-page: 1395
  year: 2019
  end-page: 403
  ident: CR102
  article-title: CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma
  publication-title: Transl Oncol
  doi: 10.1016/j.tranon.2019.07.009
– volume: 12
  start-page: 12002
  year: 2020
  end-page: 18
  ident: CR57
  article-title: Plasma endothelial cells-derived extracellular vesicles promote wound healing in diabetes through YAP and the PI3K/Akt/mTOR pathway
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.103366
– volume: 16
  start-page: 782
  year: 2008
  end-page: 90
  ident: CR163
  article-title: Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer
  publication-title: Mol Ther
  doi: 10.1038/mt.2008.1
– volume: 38
  start-page: 291
  year: 2020
  end-page: 300
  ident: CR3
  article-title: Extracellular vesicles transmit epithelial growth factor activity in the intestinal stem cell niche
  publication-title: Stem Cells
  doi: 10.1002/stem.3113
– ident: CR120
– volume: 193
  start-page: 1006
  year: 2014
  end-page: 11
  ident: CR158
  article-title: Dendritic Cell-Derived Exosomes as Immunotherapies in the Fight against Cancer
  publication-title: J IMMUNOL
  doi: 10.4049/jimmunol.1400703
– volume: 60
  start-page: 269
  year: 2019
  end-page: 78
  ident: CR53
  article-title: Activated Human Lung Fibroblasts Produce Extracellular Vesicles with Antifibrotic Prostaglandins
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2017-0248OC
– volume: 27
  start-page: 3062
  year: 2019
  end-page: 3080.e3011
  ident: CR164
  article-title: Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2019.05.008
– volume: 19
  year: 2021
  ident: CR174
  article-title: Artificial exosomes for translational nanomedicine
  publication-title: J Nanobiotechnology
  doi: 10.1186/s12951-021-00986-2
– volume: 28
  start-page: 957
  year: 2018
  end-page: 70
  ident: CR31
  article-title: Rab GTPase Function in Endosome and Lysosome Biogenesis
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2018.06.007
– ident: CR125
– volume: 7
  start-page: 1435138
  year: 2018
  ident: CR37
  article-title: Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2018.1435138
– volume: 14
  start-page: 847
  year: 2015
  end-page: 56
  ident: CR114
  article-title: PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-14-0983
– volume: 19
  start-page: 213
  year: 2018
  end-page: 28
  ident: CR1
  article-title: Shedding light on the cell biology of extracellular vesicles
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm.2017.125
– volume: 44
  start-page: 918
  year: 2014
  end-page: 22
  ident: CR110
  article-title: Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2014.2256
– volume: 35
  start-page: 1322
  year: 2020
  end-page: 30
  ident: CR151
  article-title: Advances in the discovery of exosome inhibitors in cancer
  publication-title: J Enzym Inhib Med Chem
  doi: 10.1080/14756366.2020.1754814
– volume: 10
  start-page: 2892
  year: 2019
  end-page: 906
  ident: CR67
  article-title: Exosomes from Macrophages Exposed to Apoptotic Breast Cancer Cells Promote Breast Cancer Proliferation and Metastasis
  publication-title: J Cancer
  doi: 10.7150/jca.31241
– ident: CR49
– volume: 47
  year: 2015
  ident: CR70
  article-title: Understanding of molecular mechanisms in natural killer cell therapy
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2014.114
– volume: 14
  start-page: 8603
  year: 2019
  end-page: 10
  ident: CR167
  article-title: A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S218988
– volume: 28
  start-page: 529
  year: 2021
  end-page: 42
  ident: CR52
  article-title: Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling pathway
  publication-title: Cancer Gene Ther
  doi: 10.1038/s41417-020-00238-9
– volume: 18
  start-page: 300
  year: 2020
  end-page: 10
  ident: CR103
  article-title: Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Cancer
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-19-0588
– volume: 36
  start-page: 9739
  year: 2015
  end-page: 52
  ident: CR89
  article-title: High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders
  publication-title: Tumour Biol
  doi: 10.1007/s13277-015-3741-3
– volume: 7
  start-page: 1333
  year: 2017
  end-page: 45
  ident: CR169
  article-title: Interleukin 3-receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth
  publication-title: THERANOSTICS
  doi: 10.7150/thno.17092
– volume: 21
  start-page: 493
  year: 2017
  end-page: 510
  ident: CR47
  article-title: Current and Emerging Applications of Droplet Digital PCR in Oncology
  publication-title: Mol Diagn Ther
  doi: 10.1007/s40291-017-0278-8
– volume: 5
  start-page: 31292
  year: 2016
  ident: CR119
  article-title: Exosomal miRNAs as cancer biomarkers and therapeutic targets
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v5.31292
– volume: 16
  year: 2018
  ident: CR132
  article-title: Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
  publication-title: BMC Med
  doi: 10.1186/s12916-018-1163-y
– volume: 117
  start-page: 545
  year: 2017
  end-page: 52
  ident: CR148
  article-title: Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2017.183
– volume: 4
  start-page: 2712
  year: 2013
  ident: CR26
  article-title: Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes
  publication-title: Nat Commun
  doi: 10.1038/ncomms3712
– volume: 30
  start-page: 263
  year: 2019
  end-page: 72
  ident: CR35
  article-title: The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery
  publication-title: Bioconjugate Chem
  doi: 10.1021/acs.bioconjchem.8b00732
– volume: 527
  start-page: 100
  year: 2015
  end-page: 4
  ident: CR56
  article-title: Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
  publication-title: Nature
  doi: 10.1038/nature15376
– volume: 359
  start-page: 104258
  year: 2021
  ident: CR72
  article-title: Molecular cargo in myeloid-derived suppressor cells and their exosomes
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2020.104258
– volume: 113
  start-page: 2673
  year: 2009
  end-page: 83
  ident: CR62
  article-title: Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism
  publication-title: Blood
  doi: 10.1182/blood-2008-04-153536
– volume: 560
  start-page: 382
  year: 2018
  end-page: 6
  ident: CR112
  article-title: Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
  publication-title: Nature
  doi: 10.1038/s41586-018-0392-8
– volume: 94
  start-page: 482
  year: 2019
  end-page: 94
  ident: CR22
  article-title: Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery
  publication-title: Acta Biomater
  doi: 10.1016/j.actbio.2019.05.054
– volume: 21
  start-page: 2650
  year: 2017
  end-page: 8
  ident: CR130
  article-title: MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer
  publication-title: Eur Rev Med Pharm Sci
– ident: CR21
– volume: 34
  start-page: 8521
  year: 2013
  end-page: 30
  ident: CR172
  article-title: Preformed albumin corona, a protective coating for nanoparticles based drug delivery system
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.07.102
– volume: 144
  start-page: 1444
  year: 2019
  end-page: 52
  ident: CR138
  article-title: Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31931
– volume: 11
  start-page: 7554
  year: 2005
  end-page: 63
  ident: CR15
  article-title: More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-05-0810
– volume: 12
  start-page: 163
  year: 2020
  end-page: 70
  ident: CR5
  article-title: Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP-1 cells
  publication-title: Biomed Rep
– ident: CR96
– volume: 32
  start-page: 113
  year: 2020
  end-page: 20
  ident: CR160
  article-title: Exosomes in clinical trial and their production in compliance with good manufacturing practice
  publication-title: Ci Ji Yi Xue Za Zhi
– volume: 16
  year: 2017
  ident: CR99
  article-title: Role of exosomal proteins in cancer diagnosis
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0706-8
– ident: CR50
– volume: 58
  start-page: 376
  year: 2019
  end-page: 87
  ident: CR81
  article-title: Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22935
– volume: 108
  start-page: 4852
  year: 2011
  end-page: 7
  ident: CR74
  article-title: Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1017667108
– volume: 12
  start-page: 587
  year: 2013
  end-page: 98
  ident: CR107
  article-title: Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids
  publication-title: Mol Cell Proteom
  doi: 10.1074/mcp.M112.021303
– volume: 10
  start-page: e0141448
  year: 2015
  ident: CR123
  article-title: Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0141448
– volume: 6
  start-page: 34375
  year: 2015
  end-page: 88
  ident: CR146
  article-title: Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6045
– volume: 36
  start-page: 2425
  year: 2016
  end-page: 37
  ident: CR29
  article-title: Parkin Modulates Endosomal Organization and Function of the Endo-Lysosomal Pathway
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2569-15.2016
– volume: 16
  year: 2017
  ident: CR139
  article-title: Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0714-8
– volume: 12
  start-page: 5733
  year: 2021
  ident: CR153
  article-title: A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-25990-w
– volume: 76
  start-page: 2463
  year: 2019
  end-page: 76
  ident: CR55
  article-title: Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-019-03052-1
– ident: CR105
– volume: 6
  start-page: 479
  year: 2016
  end-page: 91
  ident: CR85
  article-title: Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-15-1483
– volume: 10
  start-page: e12031
  year: 2020
  ident: CR83
  article-title: Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells
  publication-title: J Extracell Vesicles
  doi: 10.1002/jev2.12031
– volume: 8
  start-page: 14395
  year: 2017
  end-page: 407
  ident: CR149
  article-title: Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.14795
– ident: CR95
– volume: 1
  start-page: e201800093
  year: 2018
  ident: CR63
  article-title: Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC
  publication-title: Life Sci Alliance
  doi: 10.26508/lsa.201800093
– volume: 10
  start-page: e12134-n/a
  year: 2021
  ident: CR162
  article-title: Preclinical efficacy and clinical safety of clinical‐grade nebulized allogenic adipose mesenchymal stromal cells‐derived extracellular vesicles
  publication-title: J Extracell Vesicles
  doi: 10.1002/jev2.12134
– volume: 205
  start-page: 2916
  year: 2020
  end-page: 25
  ident: CR8
  article-title: Mouse 4T1 Breast Cancer Cell-Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1901104
– volume: 3
  start-page: 1156
  year: 2002
  end-page: 62
  ident: CR60
  article-title: Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes
  publication-title: Nat Immunol
  doi: 10.1038/ni854
– volume: 110
  start-page: 3173
  year: 2019
  end-page: 82
  ident: CR166
  article-title: Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells
  publication-title: Cancer Sci
  doi: 10.1111/cas.14181
– volume: 10
  start-page: 134
  year: 2012
  ident: CR155
  article-title: Exosome removal as a therapeutic adjuvant in cancer
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-10-134
– volume: 517
  start-page: 1
  year: 2021
  end-page: 13
  ident: CR78
  article-title: Small extracellular vesicle-packaged TGFbeta1 promotes the reprogramming of normal fibroblasts into cancer-associated fibroblasts by regulating fibronectin in head and neck squamous cell carcinoma
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2021.05.017
– volume: 11
  start-page: 858
  year: 2021
  end-page: 73
  ident: CR86
  article-title: Liquid Biopsy: From Discovery to Clinical Application
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-20-1311
– volume: 14
  start-page: 2847
  year: 2019
  end-page: 59
  ident: CR161
  article-title: Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S200036
– volume: 290
  start-page: 30684
  year: 2015
  end-page: 96
  ident: CR58
  article-title: Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M115.671735
– volume: 44
  start-page: 1156
  year: 2014
  end-page: 69
  ident: CR68
  article-title: Exosomes derived from human macrophages suppress endothelial cell migration by controlling integrin trafficking
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201343660
– ident: CR14
– volume: 9
  start-page: 1703244
  year: 2020
  ident: CR152
  article-title: Inhibiting extracellular vesicles formation and release: a review of EV inhibitors
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2019.1703244
– volume: 166
  start-page: 112452
  year: 2020
  ident: CR43
  article-title: Identification of programmed death ligand-1 positive exosomes in breast cancer based on DNA amplification-responsive metal-organic frameworks
  publication-title: Biosens Bioelectron
  doi: 10.1016/j.bios.2020.112452
– volume: 31
  start-page: 3412
  year: 2017
  end-page: 24
  ident: CR79
  article-title: Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes
  publication-title: FASEB J
  doi: 10.1096/fj.201601138RR
– volume: 47
  year: 2015
  ident: CR122
  article-title: Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2015.68
– volume: 515
  start-page: 568
  year: 2014
  end-page: 71
  ident: CR19
  article-title: PD-1 blockade induces responses by inhibiting adaptive immune resistance
  publication-title: Nature
  doi: 10.1038/nature13954
– volume: 126
  start-page: 5553
  year: 2013
  end-page: 65.
  ident: CR24
  article-title: Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles
  publication-title: J Cell Sci
– volume: 18
  start-page: 883
  year: 2012
  end-page: 91
  ident: CR98
  article-title: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
  publication-title: Nat Med
  doi: 10.1038/nm.2753
– volume: 9
  start-page: 1809765
  year: 2020
  ident: CR41
  article-title: Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2020.1809765
– volume: 239
  start-page: 123089
  year: 2022
  ident: CR46
  article-title: Single-particle analysis of tear fluid reveals abundant presence of tissue factor-exposing extracellular vesicles with strong coagulation activity
  publication-title: Talanta
  doi: 10.1016/j.talanta.2021.123089
– volume: 28
  start-page: 163
  year: 2019
  end-page: 73
  ident: CR131
  article-title: Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy
  publication-title: Cancer Epidemiol Biomark Prev
  doi: 10.1158/1055-9965.EPI-18-0569
– volume: 527
  start-page: 329
  year: 2015
  end-page: 35
  ident: CR33
  article-title: Tumour exosome integrins determine organotropic metastasis
  publication-title: Nature
  doi: 10.1038/nature15756
– ident: CR124
– volume: 36
  start-page: 3012
  year: 2017
  end-page: 28
  ident: CR61
  article-title: Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes
  publication-title: EMBO J
  doi: 10.15252/embj.201696003
– ident: CR48
– volume: 10
  start-page: 728616
  year: 2022
  ident: CR171
  article-title: Exosomes as Drug Carriers in Anti-Cancer Therapy
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2022.728616
– volume: 102
  start-page: 1174
  year: 2010
  end-page: 9
  ident: CR116
  article-title: Circulating microRNAs in plasma of patients with gastric cancers
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6605608
– volume: 14
  start-page: 677
  year: 2012
  end-page: 85
  ident: CR28
  article-title: Syndecan-syntenin-ALIX regulates the biogenesis of exosomes
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb2502
– volume: 56
  start-page: 167
  year: 2012
  end-page: 75
  ident: CR115
  article-title: Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.04.026
– volume: 8
  start-page: 80666
  year: 2017
  end-page: 78
  ident: CR128
  article-title: Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.20881
– volume: 319
  start-page: 1244
  year: 2008
  end-page: 7
  ident: CR25
  article-title: Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
  publication-title: Science
  doi: 10.1126/science.1153124
– volume: 29
  start-page: 223
  year: 2018
  end-page: 9
  ident: CR100
  article-title: Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdx542
– volume: 118
  start-page: 820
  year: 2018
  end-page: 4
  ident: CR113
  article-title: PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2018.9
– volume: 132
  start-page: 756
  year: 2009
  end-page: 62
  ident: CR147
  article-title: Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters
  publication-title: Am J Clin Pathol
  doi: 10.1309/AJCPAVFA8J3KHPRS
– volume: 11
  start-page: e0166027
  year: 2016
  ident: CR6
  article-title: Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0166027
– volume: 17
  year: 2018
  ident: CR140
  article-title: Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0817-x
– volume: 35
  start-page: e21505
  year: 2021
  ident: CR76
  article-title: Proteomic and phospholipidomic characterization of extracellular vesicles inducing tumor microenvironment in Epstein-Barr virus-associated lymphomas
  publication-title: FASEB J
  doi: 10.1096/fj.202002730R
– volume: 1
  start-page: 1074
  year: 2012
  end-page: 83
  ident: CR10
  article-title: Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands
  publication-title: Oncoimmunology
  doi: 10.4161/onci.20897
– ident: CR141
– volume: 11
  year: 2020
  ident: CR7
  article-title: Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-15569-2
– volume: 5
  year: 2014
  ident: CR44
  article-title: Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
  publication-title: Nat Commun
  doi: 10.1038/ncomms4591
– volume: 4
  start-page: 26659
  year: 2015
  ident: CR97
  article-title: Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v4.26659
– volume: 14
  start-page: e0215990
  year: 2019
  ident: CR94
  article-title: Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0215990
– volume: 112
  start-page: 532
  year: 2015
  end-page: 8
  ident: CR127
  article-title: Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2014.621
– volume: 25
  start-page: 981
  year: 2015
  end-page: 4
  ident: CR142
  article-title: Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis
  publication-title: Cell Res
  doi: 10.1038/cr.2015.82
– volume: 47
  year: 2015
  ident: 431_CR122
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2015.68
– volume: 126
  start-page: 1224
  year: 2016
  ident: 431_CR159
  publication-title: J CLIN INVEST
  doi: 10.1172/JCI81137
– volume: 76
  start-page: 2463
  year: 2019
  ident: 431_CR55
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-019-03052-1
– ident: 431_CR48
  doi: 10.1038/s41467-018-07947-8
– ident: 431_CR106
  doi: 10.1038/s41467-020-18311-0
– volume: 61
  start-page: 16
  year: 2021
  ident: 431_CR69
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2021.08.002
– ident: 431_CR91
  doi: 10.1080/2162402X.2019.1593805
– volume: 4
  start-page: 26659
  year: 2015
  ident: 431_CR97
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v4.26659
– volume: 94
  start-page: 482
  year: 2019
  ident: 431_CR22
  publication-title: Acta Biomater
  doi: 10.1016/j.actbio.2019.05.054
– volume: 10
  start-page: 134
  year: 2012
  ident: 431_CR155
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-10-134
– volume: 17
  year: 2018
  ident: 431_CR136
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0831-z
– volume: 60
  start-page: 269
  year: 2019
  ident: 431_CR53
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2017-0248OC
– ident: 431_CR95
  doi: 10.3390/cancers11030429
– volume: 21
  start-page: 1228
  year: 2017
  ident: 431_CR129
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.13056
– volume: 29
  start-page: 223
  year: 2018
  ident: 431_CR100
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdx542
– volume: 21
  start-page: 2650
  year: 2017
  ident: 431_CR130
  publication-title: Eur Rev Med Pharm Sci
– volume: 2014
  start-page: 864894
  year: 2014
  ident: 431_CR121
  publication-title: Biomed Res Int
– volume: 6
  start-page: 34375
  year: 2015
  ident: 431_CR146
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6045
– ident: 431_CR21
  doi: 10.4049/jimmunol.1400703
– ident: 431_CR36
  doi: 10.3402/jev.v2i0.20360
– volume: 38
  start-page: 310
  year: 2019
  ident: 431_CR66
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1313-x
– volume: 379
  start-page: 958
  year: 2018
  ident: 431_CR88
  publication-title: N. Engl J Med
  doi: 10.1056/NEJMra1704286
– ident: 431_CR96
  doi: 10.3390/cancers11101449
– volume: 9
  start-page: 1697028
  year: 2020
  ident: 431_CR45
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2019.1697028
– volume: 10
  start-page: 2892
  year: 2019
  ident: 431_CR67
  publication-title: J Cancer
  doi: 10.7150/jca.31241
– volume: 9
  year: 2019
  ident: 431_CR173
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-41800-2
– volume: 36
  start-page: 2425
  year: 2016
  ident: 431_CR29
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2569-15.2016
– volume: 108
  start-page: 4852
  year: 2011
  ident: 431_CR74
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1017667108
– volume: 9
  start-page: 643
  year: 2005
  ident: 431_CR157
  publication-title: J CELL MOL MED
  doi: 10.1111/j.1582-4934.2005.tb00494.x
– volume: 20
  year: 2022
  ident: 431_CR168
  publication-title: J Nanobiotechnology
  doi: 10.1186/s12951-022-01472-z
– volume: 17
  start-page: 816
  year: 2015
  ident: 431_CR4
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb3169
– volume: 8
  start-page: 80666
  year: 2017
  ident: 431_CR128
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.20881
– volume: 39
  start-page: 6529
  year: 2020
  ident: 431_CR75
  publication-title: Oncogene
  doi: 10.1038/s41388-020-01450-5
– volume: 11
  year: 2020
  ident: 431_CR7
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-15569-2
– volume: 289
  start-page: 3869
  year: 2014
  ident: 431_CR144
  publication-title: J Biol Chem
  doi: 10.1074/jbc.C113.532267
– volume: 117
  start-page: 545
  year: 2017
  ident: 431_CR148
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2017.183
– volume: 77
  start-page: 3965
  year: 2017
  ident: 431_CR137
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-2634
– ident: 431_CR134
  doi: 10.1038/s41388-019-0771-0
– volume: 9
  start-page: 1809765
  year: 2020
  ident: 431_CR41
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2020.1809765
– volume: 31
  start-page: 3412
  year: 2017
  ident: 431_CR79
  publication-title: FASEB J
  doi: 10.1096/fj.201601138RR
– volume: 1808
  start-page: 2638
  year: 2011
  ident: 431_CR145
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamem.2011.07.026
– volume: 34
  start-page: 8521
  year: 2013
  ident: 431_CR172
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.07.102
– volume: 1
  start-page: e201800093
  year: 2018
  ident: 431_CR63
  publication-title: Life Sci Alliance
  doi: 10.26508/lsa.201800093
– ident: 431_CR124
  doi: 10.1002/jcb.27165
– volume: 17
  year: 2018
  ident: 431_CR12
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0897-7
– ident: 431_CR141
  doi: 10.1186/s12943-019-1041-z
– volume: 16
  year: 2017
  ident: 431_CR139
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0714-8
– volume: 527
  start-page: 100
  year: 2015
  ident: 431_CR56
  publication-title: Nature
  doi: 10.1038/nature15376
– volume: 319
  start-page: 1244
  year: 2008
  ident: 431_CR25
  publication-title: Science
  doi: 10.1126/science.1153124
– volume: 375
  start-page: 1823
  year: 2016
  ident: 431_CR20
  publication-title: N. Engl J Med
  doi: 10.1056/NEJMoa1606774
– volume: 14
  start-page: 677
  year: 2012
  ident: 431_CR28
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb2502
– volume: 110
  start-page: 3173
  year: 2019
  ident: 431_CR166
  publication-title: Cancer Sci
  doi: 10.1111/cas.14181
– volume: 5
  year: 2014
  ident: 431_CR44
  publication-title: Nat Commun
  doi: 10.1038/ncomms4591
– volume: 10
  start-page: 3843
  year: 2017
  ident: 431_CR126
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S140062
– volume: 367
  start-page: 26
  year: 2015
  ident: 431_CR87
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.07.014
– volume: 18
  start-page: 300
  year: 2020
  ident: 431_CR103
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-19-0588
– volume: 397
  start-page: 33
  year: 2017
  ident: 431_CR2
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2017.03.004
– volume: 11
  start-page: 7554
  year: 2005
  ident: 431_CR15
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-05-0810
– volume: 28
  start-page: 957
  year: 2018
  ident: 431_CR31
  publication-title: Trends Cell Biol
  doi: 10.1016/j.tcb.2018.06.007
– volume: 24
  start-page: 766
  year: 2014
  ident: 431_CR143
  publication-title: Cell Res
  doi: 10.1038/cr.2014.44
– volume: 19
  year: 2021
  ident: 431_CR174
  publication-title: J Nanobiotechnology
  doi: 10.1186/s12951-021-00986-2
– volume: 44
  start-page: 1156
  year: 2014
  ident: 431_CR68
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201343660
– volume: 32
  start-page: 1059
  year: 2016
  ident: 431_CR118
  publication-title: Pediatr Surg Int
  doi: 10.1007/s00383-016-3960-8
– volume: 27
  start-page: 585
  year: 2020
  ident: 431_CR165
  publication-title: Drug Deliv
  doi: 10.1080/10717544.2020.1748758
– volume: 27
  start-page: 3062
  year: 2019
  ident: 431_CR164
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2019.05.008
– volume: 1
  start-page: 1074
  year: 2012
  ident: 431_CR10
  publication-title: Oncoimmunology
  doi: 10.4161/onci.20897
– volume: 32
  start-page: 113
  year: 2020
  ident: 431_CR160
  publication-title: Ci Ji Yi Xue Za Zhi
– ident: 431_CR50
  doi: 10.1186/s12943-022-01509-9
– volume: 32
  start-page: 490
  year: 2014
  ident: 431_CR108
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2886
– volume: 35
  start-page: 1322
  year: 2020
  ident: 431_CR151
  publication-title: J Enzym Inhib Med Chem
  doi: 10.1080/14756366.2020.1754814
– volume: 28
  start-page: 163
  year: 2019
  ident: 431_CR131
  publication-title: Cancer Epidemiol Biomark Prev
  doi: 10.1158/1055-9965.EPI-18-0569
– volume: 527
  start-page: 329
  year: 2015
  ident: 431_CR33
  publication-title: Nature
  doi: 10.1038/nature15756
– volume: 182
  start-page: 1044
  year: 2020
  ident: 431_CR111
  publication-title: Cell
  doi: 10.1016/j.cell.2020.07.009
– volume: 18
  start-page: 10
  year: 2020
  ident: 431_CR170
  publication-title: J Nanobiotechnology
  doi: 10.1186/s12951-019-0563-2
– volume: 14
  start-page: 8603
  year: 2019
  ident: 431_CR167
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S218988
– volume: 8
  start-page: 14395
  year: 2017
  ident: 431_CR149
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.14795
– volume: 50
  start-page: 472
  year: 2007
  ident: 431_CR109
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2007.02635.x
– ident: 431_CR125
  doi: 10.1002/jcb.26650
– volume: 4
  start-page: 2712
  year: 2013
  ident: 431_CR26
  publication-title: Nat Commun
  doi: 10.1038/ncomms3712
– volume: 560
  start-page: 382
  year: 2018
  ident: 431_CR112
  publication-title: Nature
  doi: 10.1038/s41586-018-0392-8
– volume: 100
  start-page: 113
  year: 2000
  ident: 431_CR104
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81688-8
– volume: 506
  start-page: 11
  year: 2021
  ident: 431_CR77
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2021.01.006
– volume: 16
  year: 2018
  ident: 431_CR132
  publication-title: BMC Med
  doi: 10.1186/s12916-018-1163-y
– volume: 11
  start-page: 6445
  year: 2020
  ident: 431_CR16
  publication-title: J Cancer
  doi: 10.7150/jca.48531
– volume: 17
  start-page: 16
  year: 2019
  ident: 431_CR32
  publication-title: J Nanobiotechnology
  doi: 10.1186/s12951-018-0437-z
– volume: 36
  start-page: 9739
  year: 2015
  ident: 431_CR89
  publication-title: Tumour Biol
  doi: 10.1007/s13277-015-3741-3
– volume: 10
  start-page: 728616
  year: 2022
  ident: 431_CR171
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2022.728616
– ident: 431_CR150
  doi: 10.7150/thno.21945
– ident: 431_CR80
  doi: 10.3390/ijms23042180
– volume: 359
  start-page: 104258
  year: 2021
  ident: 431_CR72
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2020.104258
– volume: 12
  start-page: 5733
  year: 2021
  ident: 431_CR153
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-25990-w
– volume: 515
  start-page: 568
  year: 2014
  ident: 431_CR19
  publication-title: Nature
  doi: 10.1038/nature13954
– volume: 290
  start-page: 30684
  year: 2015
  ident: 431_CR58
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M115.671735
– volume: 193
  start-page: 1006
  year: 2014
  ident: 431_CR158
  publication-title: J IMMUNOL
  doi: 10.4049/jimmunol.1400703
– volume: 11
  start-page: e0166027
  year: 2016
  ident: 431_CR6
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0166027
– volume: 25
  start-page: 981
  year: 2015
  ident: 431_CR142
  publication-title: Cell Res
  doi: 10.1038/cr.2015.82
– volume: 11
  year: 2020
  ident: 431_CR17
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-18311-0
– volume: 56
  start-page: 167
  year: 2012
  ident: 431_CR115
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.04.026
– volume: 102
  start-page: 1174
  year: 2010
  ident: 431_CR116
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6605608
– volume: 10
  start-page: 9303
  year: 2020
  ident: 431_CR40
  publication-title: Theranostics
  doi: 10.7150/thno.46568
– volume: 8
  start-page: 706
  year: 2020
  ident: 431_CR156
  publication-title: Vaccines (Basel)
  doi: 10.3390/vaccines8040706
– volume: 166
  start-page: 112452
  year: 2020
  ident: 431_CR43
  publication-title: Biosens Bioelectron
  doi: 10.1016/j.bios.2020.112452
– volume: 35
  start-page: e21505
  year: 2021
  ident: 431_CR76
  publication-title: FASEB J
  doi: 10.1096/fj.202002730R
– ident: 431_CR49
  doi: 10.1021/jacs.9b13960
– volume: 126
  start-page: 5553
  year: 2013
  ident: 431_CR24
  publication-title: J Cell Sci
– ident: 431_CR120
  doi: 10.1126/science.aau6977
– volume: 4
  start-page: e4942
  year: 2009
  ident: 431_CR9
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0004942
– volume: 12
  start-page: 12002
  year: 2020
  ident: 431_CR57
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.103366
– volume: 10
  start-page: e0141448
  year: 2015
  ident: 431_CR123
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0141448
– volume: 75
  start-page: 193
  year: 2017
  ident: 431_CR30
  publication-title: Cell Mol life Sci: CMLS
  doi: 10.1007/s00018-017-2595-9
– volume: 14
  start-page: e0215990
  year: 2019
  ident: 431_CR94
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0215990
– volume: 6
  start-page: 479
  year: 2016
  ident: 431_CR85
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-15-1483
– volume: 36
  start-page: 3012
  year: 2017
  ident: 431_CR61
  publication-title: EMBO J
  doi: 10.15252/embj.201696003
– volume: 4
  start-page: 27031
  year: 2015
  ident: 431_CR38
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v4.27031
– ident: 431_CR71
  doi: 10.1126/scitranslmed.aaz3426
– volume: 21
  start-page: 838
  year: 2017
  ident: 431_CR101
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.12941
– volume: 7
  start-page: 1333
  year: 2017
  ident: 431_CR169
  publication-title: THERANOSTICS
  doi: 10.7150/thno.17092
– volume: 38
  start-page: 1685
  year: 2002
  ident: 431_CR154
  publication-title: EUR J CANCER
  doi: 10.1016/S0959-8049(02)00166-1
– volume: 73
  start-page: 1144
  year: 2020
  ident: 431_CR54
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2020.04.044
– volume: 32
  start-page: 490
  year: 2014
  ident: 431_CR18
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2886
– volume: 44
  start-page: 918
  year: 2014
  ident: 431_CR110
  publication-title: Int J Oncol
  doi: 10.3892/ijo.2014.2256
– volume: 10
  start-page: 1528
  year: 2009
  ident: 431_CR27
  publication-title: Traffic
  doi: 10.1111/j.1600-0854.2009.00963.x
– volume: 12
  start-page: 1395
  year: 2019
  ident: 431_CR102
  publication-title: Transl Oncol
  doi: 10.1016/j.tranon.2019.07.009
– volume: 8
  year: 2017
  ident: 431_CR135
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01942-1
– ident: 431_CR14
  doi: 10.3390/cancers11030429
– volume: 30
  start-page: 263
  year: 2019
  ident: 431_CR35
  publication-title: Bioconjugate Chem
  doi: 10.1021/acs.bioconjchem.8b00732
– volume: 7
  start-page: 2002157
  year: 2020
  ident: 431_CR82
  publication-title: Adv Sci (Weinh)
  doi: 10.1002/advs.202002157
– volume: 11
  start-page: 858
  year: 2021
  ident: 431_CR86
  publication-title: Cancer Disco
  doi: 10.1158/2159-8290.CD-20-1311
– volume: 9
  start-page: 1703244
  year: 2020
  ident: 431_CR152
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2019.1703244
– volume: 16
  year: 2017
  ident: 431_CR99
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0706-8
– volume: 96
  start-page: 93
  year: 2017
  ident: 431_CR90
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2016.09.010
– volume: 14
  start-page: 2847
  year: 2019
  ident: 431_CR161
  publication-title: Int J Nanomed
  doi: 10.2147/IJN.S200036
– volume: 14
  start-page: 847
  year: 2015
  ident: 431_CR114
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-14-0983
– volume: 239
  start-page: 123089
  year: 2022
  ident: 431_CR46
  publication-title: Talanta
  doi: 10.1016/j.talanta.2021.123089
– volume: 10
  start-page: e12031
  year: 2020
  ident: 431_CR83
  publication-title: J Extracell Vesicles
  doi: 10.1002/jev2.12031
– volume: 38
  start-page: 291
  year: 2020
  ident: 431_CR3
  publication-title: Stem Cells
  doi: 10.1002/stem.3113
– volume: 492
  start-page: 71
  year: 2020
  ident: 431_CR51
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2020.08.030
– volume: 18
  start-page: 883
  year: 2012
  ident: 431_CR98
  publication-title: Nat Med
  doi: 10.1038/nm.2753
– ident: 431_CR39
  doi: 10.1080/20013078.2020.1791450
– volume: 144
  start-page: 1444
  year: 2019
  ident: 431_CR138
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31931
– ident: 431_CR13
  doi: 10.3402/jev.v4.26659
– volume: 113
  start-page: 2673
  year: 2009
  ident: 431_CR62
  publication-title: Blood
  doi: 10.1182/blood-2008-04-153536
– volume: 3
  year: 2005
  ident: 431_CR64
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-3-9
– volume: 32
  start-page: 579
  year: 2014
  ident: 431_CR84
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.45.2011
– ident: 431_CR117
  doi: 10.3390/jcm5030030
– volume: 7
  year: 2017
  ident: 431_CR133
  publication-title: Sci Rep
  doi: 10.1038/srep42339
– volume: 523
  start-page: 177
  year: 2015
  ident: 431_CR11
  publication-title: Nature
  doi: 10.1038/nature14581
– volume: 438
  start-page: 152
  year: 2013
  ident: 431_CR73
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2013.07.044
– volume: 205
  start-page: 2916
  year: 2020
  ident: 431_CR8
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1901104
– volume: 10
  start-page: e12134-n/a
  year: 2021
  ident: 431_CR162
  publication-title: J Extracell Vesicles
  doi: 10.1002/jev2.12134
– ident: 431_CR105
  doi: 10.1073/pnas.1618088114
– volume: 12
  start-page: 163
  year: 2020
  ident: 431_CR5
  publication-title: Biomed Rep
– volume: 132
  start-page: 756
  year: 2009
  ident: 431_CR147
  publication-title: Am J Clin Pathol
  doi: 10.1309/AJCPAVFA8J3KHPRS
– volume: 3
  start-page: 1156
  year: 2002
  ident: 431_CR60
  publication-title: Nat Immunol
  doi: 10.1038/ni854
– volume: 38
  start-page: 81
  year: 2019
  ident: 431_CR65
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1095-1
– ident: 431_CR92
  doi: 10.1158/1078-0432.CCR-18-1941
– volume: 118
  start-page: 820
  year: 2018
  ident: 431_CR113
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2018.9
– volume: 19
  start-page: 47
  year: 2021
  ident: 431_CR34
  publication-title: Cell Commun Signal
  doi: 10.1186/s12964-021-00730-1
– volume: 12
  start-page: 587
  year: 2013
  ident: 431_CR107
  publication-title: Mol Cell Proteom
  doi: 10.1074/mcp.M112.021303
– volume: 19
  start-page: 213
  year: 2018
  ident: 431_CR1
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm.2017.125
– volume: 35
  start-page: 89
  year: 2005
  ident: 431_CR59
  publication-title: Blood Cells Mol Dis
  doi: 10.1016/j.bcmd.2005.05.003
– volume: 10
  start-page: 1802
  year: 2016
  ident: 431_CR42
  publication-title: ACS Nano
  doi: 10.1021/acsnano.5b07584
– volume: 17
  year: 2018
  ident: 431_CR140
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0817-x
– volume: 5
  start-page: 31292
  year: 2016
  ident: 431_CR119
  publication-title: J Extracell Vesicles
  doi: 10.3402/jev.v5.31292
– volume: 47
  year: 2015
  ident: 431_CR70
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2014.114
– volume: 58
  start-page: 376
  year: 2019
  ident: 431_CR81
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22935
– volume: 21
  start-page: 493
  year: 2017
  ident: 431_CR47
  publication-title: Mol Diagn Ther
  doi: 10.1007/s40291-017-0278-8
– volume: 517
  start-page: 1
  year: 2021
  ident: 431_CR78
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2021.05.017
– volume: 7
  start-page: 1333
  year: 2017
  ident: 431_CR23
  publication-title: Theranostics
  doi: 10.7150/thno.17092
– volume: 38
  start-page: 93
  year: 2019
  ident: 431_CR93
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-019-09783-8
– volume: 112
  start-page: 532
  year: 2015
  ident: 431_CR127
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2014.621
– volume: 7
  start-page: 1435138
  year: 2018
  ident: 431_CR37
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2018.1435138
– volume: 28
  start-page: 529
  year: 2021
  ident: 431_CR52
  publication-title: Cancer Gene Ther
  doi: 10.1038/s41417-020-00238-9
– volume: 16
  start-page: 782
  year: 2008
  ident: 431_CR163
  publication-title: Mol Ther
  doi: 10.1038/mt.2008.1
SSID ssj0000561655
Score 2.6090438
SecondaryResourceType review_article
Snippet Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional molecular...
Abstract Exosomes belong to a subpopulation of extracellular vesicles secreted by the dynamic multistep endocytosis process and carry diverse functional...
SourceID doaj
pubmedcentral
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 54
SubjectTerms 631/67
631/67/1857
Apoptosis
Biomarkers
Cancer
Cell Biology
Drug development
Endocytosis
Exosomes
Extracellular vesicles
Human Genetics
Immunosuppressive agents
Internal Medicine
Lipid metabolism
Medicine
Medicine & Public Health
Oncology
Review
Review Article
Therapeutic targets
SummonAdditionalLinks – databaseName: Science Database (ProQuest)
  dbid: M2P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9UwDI9gIMSF8SkKGyoSN4jWNMlrckKwD3HZNCGQdovSOGGTRjvat4k_nzjNe6OT2IVjE7tNYzv5KXZsQt5BFUJohaQR2nsq4oZLrVSailY7DnUE2BBSsYnm6EidnOjjfOA25rDK1ZqYFmroHZ6R79QNw0zvWsqPF78oVo1C72ouoXGX3IvIhmFI12F9vD5jQXS8kDLflam42hkFOuYohrCjD4xROduPUtr-Gda8GSl5w12adqGDzf8d_2PyKOPP8tOkME_IHd89JQ8Os4f9Gfm6_7sf-59-LG0HpUOdGEpa7k0ReZEptWNUV37E-_sY4jNMHH_d5yqv_Cl-5Dn5frD_bfcLzXUXqJOKL6lsmFOtCw2zEGwlAmsDAw1OeeZ1wBLV1tZQVV7xRROiUNsATaU8VA5aVfMXZKPrO_-SlKC8d63kWumF0BFbxDdEzoi7XKQVuiBsNfvG5aTkWBvj3CTnOFdmkpiJEjNJYkYW5P2a52JKyXEr9WcU6poS02mnhn74YbJ1Ggg8wibGPWu9CA50LW1juVVRdwEEFGRrJVSTbXw01xItyNt1d7ROdLnYzveXiUYKrqSuCtLMVGk2oHlPd3aa8nxr0UT8Fufow0rprj_-7x9-dftYX5OHdVJ_TZncIhvL4dJvk_vuank2Dm-S_fwBHXQkCg
  priority: 102
  providerName: ProQuest
Title Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle
URI https://link.springer.com/article/10.1038/s41389-022-00431-5
https://www.proquest.com/docview/2714788955
https://www.proquest.com/docview/2715438590
https://pubmed.ncbi.nlm.nih.gov/PMC9477829
https://doaj.org/article/df391013e1be4fcd925a7a3a8441dd4d
Volume 11
WOSCitedRecordID wos000854766400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2157-9024
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000561655
  issn: 2157-9024
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2157-9024
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000561655
  issn: 2157-9024
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LbtQw0IKCUC8VT7FQVkHiBlbt2F7bxz62gsOuogqk5WQ5fqiVIIs226onvp2xk102lYALF0uJZ_yYGWcmmvEMQu88iTHWXGAw7QPmoHCxFUpjXmvHfAkGto-52IScz9VioaudUl8pJqxLD9wR7shHBhqNskDrwKPzuhRWWmYVDOs99-nrS6Te-ZnqsnpP6ESI_pYMYeqo5cklh1PwevJ-USwGmign7B9YmXdjJO84SrP-OX-MDnrDsTjuFvwE3QvNU_Ro1rvGn6GL6e2yXX4PbWEbX7jEzFWBi7MulA6Q8vsUjtU_pov3KTZn1WHsXMQqbsJlmuQ5-nI-_Xz6EfcFE7ATiq2xkNSp2kVJrY-W8EjrSL32TgUadEy1pa0tPSFBsYmMwI06eklU8MT5WpXsBdprlk14iQqvQnC1YFrpCddgFMAIgAkGkwNYrkeIbohnXJ9NPBW1-GayV5sp0xHcAMFNJrgRI_R-i_Ojy6XxV-iTxJMtZMqDnV-AdJheOsy_pGOEDjccNf3hbE0paSoaoAXM8XbbDccq-UpsE5bXGUZwpoQmIyQHkjBY0LCnubrMCbo1l2B4AY0-bGTm9-R_3vCr_7Hh12i_zDKuMRWHaG-9ug5v0EN3s75qV2N0Xy5kbtUYPTiZzquLcT440M7KKrUytz-n0F99mlVffwFxxR7I
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VBQEX3ohAgSDBCazGsb2xDwgBbdWq7apCRerNJH7QSpCUzbbAn-I34nGSLalEbz1wjB-JH5_HXzzjGYAXNvPeV1yQQO0d4WHDJaWQivBKGWbzQLCtj8EmiulUHhyovSX4PdyFQbPKQSZGQW0bg2fkq3lB0dO7EuLt8XeCUaNQuzqE0Ohgse1-_Qi_bO2brbUwvy_zfGN9_8Mm6aMKECMkmxNRUCMr4wtaWl9m3NPKU6uskY465TEAc1nmNsucZJPChyZX3haZdDYztpLo6CCI_CscPYuhqWC-tzjTQTY-EaK_m5MxudpyVAQSNJlHnRslYrT_xTABI2573jLznHo27nobt_638boNN3t-nb7rFsQdWHL1Xbi221sQ3IOP6z-btvnm2rSsbWoQ87OUpGudxWGoFNPRaq1_RP8EaMI062r8dV8tPXWH-JH78OlSevQAluumdg8htdI5UwmmpJpwFbhTeEOoGXilCWW5SoAOs61N73QdY3981VH5z6TuEKIDQnREiBYJvFrUOe5cjlxY-j2CaFES3YXHhGb2RffSR1vPAi2kzNHKcW-sykVZlKyUYW1ay20CKwOIdC_DWn2GoASeL7KD9EGVUlm75iSWEZxJobIEihF0Rw0a59RHh9GPueJF4KdhjF4PID_7-L87_Ojitj6D65v7uzt6Z2u6_Rhu5HHpKULFCizPZyfuCVw1p_OjdvY0rt0UPl82-P8AWu6EkQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB1VW1Rx4Rs1UCBIcAJr48Te2AeEgO2KVelqhUAqJ5P4g1aCpGy2Bf4av46xk2zZSvTWA8ckduIkb8YvmecZgCcmcc6VjBOk9pYwnHBJwYUkrJQ6MykSbONCsYl8NhMHB3K-Ab_7tTBeVtn7xOCoTa39P_JhmlOf6V1yPnSdLGI-nrw8_k58BSkfae3LabQQ2bO_fuDnW_NiOsZ3_TRNJ7sf3rwlXYUBornIloTnVItSu5wWxhUJc7R01EijhaVWOl-MuShSkyRWZKPc4fBLZ_JEWJNoUwqf9ADd_yZScpYOYHM-3Z9_Wv3h8dx8xHm3UifJxLBhPixIvIDeR-Ao4WuzYSgasMZ0z-s0zwVrwxw4uf4_P70bcK1j3vGr1lRuwoatbsHWfqctuA3vd3_WTf3NNnFRmVh7a1jEJB63WkTsFPZ7PVu36TMXeHHTou3x10q2-NQe-ovcgY-Xckd3YVDVld2G2AhrdckzKeSISWRVeAbsiYxTY1smI6D9m1e6S8fuq4J8VUEWkAnVokUhWlRAi-IRPFv1OW6TkVzY-rUH1KqlTyQedtSLL6rzS8q4DAkjzSwtLXPayJQXeZEVAq3WGGYi2OkBpTrv1qgzNEXweHUY_ZIPNhWVrU9CG84ywWUSQb4G47UBrR-pjg5DhnPJcmSu-Iye94A_u_i_b_jexWN9BFuIefVuOtu7D1fTYIWSUL4Dg-XixD6AK_p0edQsHnaGHMPny0b_HyeIjto
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomes+and+cancer+-+Diagnostic+and+prognostic+biomarkers+and+therapeutic+vehicle&rft.jtitle=Oncogenesis+%28New+York%2C+NY%29&rft.au=Wang%2C+Xia&rft.au=Tian%2C+Lu&rft.au=Lu%2C+Jingyi&rft.au=Ng%2C+Irene+Oi-Lin&rft.date=2022-09-15&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2157-9024&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41389-022-00431-5&rft_id=info%3Apmid%2F36109501&rft.externalDocID=PMC9477829
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-9024&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-9024&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-9024&client=summon